Life Science and Chemical Instrumentation Market Report 2025

The life science and chemical instrumentation market size has grown strongly in recent years. It will grow from $58.23 billion in 2024 to $62.3 billion in 2025 at a compound annual growth rate (CAGR) of 7%. The growth in the historic period can be attributed to increasing R&D activities, stringent regulations, growing healthcare expenditure, globalization of research, government regulations.

The life science and chemical instrumentation market size is expected to see strong growth in the next few years. It will grow to $85.57 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing regulatory complexity, expanding applications in personalized medicine, growth of emerging markets, rising focus on environmental testing. Major trends in the forecast period include technological advancements in analytical instruments, product innovations, focus on green and sustainable technologies, integration of IoT and big data analytics.

The increasing prevalence of chronic diseases is anticipated to drive the growth of the life science and chemical instrumentation market in the coming years. Chronic diseases are conditions that last for a year or longer and may worsen over time, requiring ongoing medical care and potentially limiting daily activities. The most common chronic diseases include cancer, heart disease, stroke, diabetes, and arthritis. Life science and chemical instrumentation play a crucial role in conducting quality tests on products, monitoring and controlling manufacturing processes, assessing food product quality, and managing laboratory information related to chronic diseases. For example, in January 2022, the American Cancer Society, a US-based nonprofit organization focused on cancer awareness, projected that the US would see approximately 1.9 million new cancer cases and 609,360 cancer-related deaths, averaging around 1,670 deaths daily. Thus, the rising prevalence of chronic diseases is propelling the growth of the life science and chemical instrumentation market.

Increasing investments in research and development (R&D) are expected to drive the growth of the life science and chemical instrumentation market in the coming years. R&D investments involve the allocation of financial and human resources toward activities focused on discovering, creating, and improving new products, services, technologies, or processes. These investments are essential for advancing life science and chemical instrumentation, enabling scientists and engineers to expand knowledge, develop innovative technologies, and tackle significant challenges in healthcare, environmental sustainability, and other areas. For instance, in December 2023, Eurostat, the Luxembourg-based statistical office of the European Union, reported that in 2022, the EU's expenditure on R&D rose to €352 billion ($384.42 billion), representing a 6.34% increase from €331 billion ($361.48 billion) in the previous year. Thus, the growth in R&D investments is propelling the life science and chemical instrumentation market.

Technological advancements in analytical instruments are a significant trend gaining traction in the life science and chemical instrumentation market. Leading companies in this sector are concentrating on delivering innovative technologies to enhance their market position. For example, in October 2023, Shimadzu Corporation, a Japanese manufacturer of analytical instruments, introduced the Brevis GC-2050. This instrument is designed for scalability, enabling connections to auto-samplers, mass spectrometers, and various other accessories, all while maintaining a compact width of just 35 cm. Additionally, it features a 30% reduction in energy consumption compared to traditional models and minimizes helium usage, thereby promoting environmental sustainability. The Brevis GC-2050 represents a compact and sophisticated gas chromatography system equipped with intelligent automated functionalities.

Key players in the life science and chemical instrumentation market are strategically introducing advanced technological solutions like automated sample preparation systems to gain a competitive edge. These systems, streamlining sample prep processes in life sciences and chemical analysis, offer enhanced efficiency and accuracy while reducing repetitive task allocation. For instance, in March 2022, Beckman Coulter Life Sciences launched CellMek SPS, an automated sample preparation system for clinical flow cytometry. It mitigates manual preparation bottlenecks by offering traceable and analysis-ready samples, utilizing integrated cell wash modules and enabling up to 53 vial storage with chilled liquid antibody carousels. The system's adaptability is further augmented by premade reagent mixtures, enhancing its capacity.

In August 2024, Spectris, a UK-based instrumentation company, acquired Micromeritics for $600 million. This acquisition aims to establish a leading global presence in particle characterization by leveraging Micromeritics' expertise in analytical instrumentation, thereby enhancing Spectris' offerings in high-growth markets such as clean technology. Through this strategic move, Spectris intends to provide a comprehensive suite of solutions that encompasses the entire customer workflow, from research and development to quality control. Micromeritics, based in Georgia, is known for manufacturing instruments that measure surface area, porosity, density, and chemical activity.

Major companies operating in the life science and chemical instrumentation market are Agilent Technologies Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, PerkinElmer Inc., Thermo Fisher Scientific Inc., Waters Corporation, F. Hoffmann-La Roche Ltd., Illumina Inc., Shimadzu Corporation, General Electric Healthcare LLC, Hitachi High-Technologies Corporation, JEOL Ltd., Oxford Instruments PLC, Rigaku Corporation, Sigma-Aldrich Corporation, SRI Instruments, Analytik Jena AG, Biochrom Ltd., BioTek Instruments Inc., Cole-Parmer Instrument Company LLC, Eppendorf AG, Harvard Bioscience Inc., HORIBA Ltd., Labconco Corporation, Mettler-Toledo International Inc., New England Biolabs Inc., QIAGEN N.V.

North America was the largest region in the life science and chemical instrumentation market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the life science and chemical instrumentation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the life science and chemical instrumentation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Life science and chemical instrumentation represent critical medical devices employed for quality testing, process control, and monitoring in manufacturing plants, as well as for assessing food product quality and managing laboratory data. These instruments play pivotal roles in overseeing and regulating processes across industrial research and development labs, the pharmaceutical sector, biotechnology, and academic institutions.

Key technologies within life science and chemical instrumentation encompass polymerase chain reaction (PCR), DNA sequencers, amplifiers, flow cytometry, spectroscopy, electrophoresis, chromatography, centrifuges, and various other methods. For instance, PCR, facilitating the rapid amplification of DNA segments, finds broad applications in cell culture, cancer research, drug discovery, genomics, in vitro fertilization, bioprocessing, metabolomics, proteomics, and other fields. These instruments cater to diverse end-users, including hospitals, diagnostic centers, pharmaceutical and biotech firms, contract research organizations (CROs), academia, and research institutes.

The life science and chemical instrumentation market research report is one of a series of new reports that provides life science and chemical instrumentation market statistics, including life science and chemical instrumentation industry global market size, regional shares, competitors with a life science and chemical instrumentation market share, detailed life science and chemical instrumentation market segments, market trends and opportunities, and any further data you may need to thrive in the life science and chemical instrumentation industry. This life science and chemical instrumentation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The life science and chemical instrumentation market consists of sales of medical equipment such as liquid chromatography, molecular spectroscopy, electron microscopes, and cell analyzers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.